World Trade Organization Continues to Allow Subsidized Overfishing
Globe Newswire2-03-2024, 07:06
MoonLake Immunotherapeutics announces the full dataset from its 24-week MIRA clinical trial, establishing the Nanobody® sonelokimab as a highly promising and differentiated therapeutic solution for Hidradenitis Suppurativa 15-10-2023, 20:03